Menu Search
Equities

Cardinal Health Inc

CLH:MUN

Cardinal Health Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)100.35
  • Today's Change1.15 / 1.16%
  • Shares traded0.00
  • 1 Year change+38.41%
  • Beta--
Data delayed at least 15 minutes, as of Apr 16 2024 07:04 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products and laboratory product solutions. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. The Company's segments include Pharmaceutical and Medical. Its Pharmaceutical segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets.

  • Revenue in USD (TTM)216.15bn
  • Net income in USD639.00m
  • Incorporated1979
  • Employees48.00k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		CAH:NYQ since
announced		Transaction
value
Specialty Networks LLCAnnounced31 Jan 202431 Jan 2024Announced0.10%1.20bn
Data delayed at least 15 minutes, as of Apr 16 2024 21:10 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.